Recent developments in antifungal susceptibility testing

Clinical Microbiology Newsletter

Volumn 13, Issue 11, 1991, Pages 81-85

  LaRocco, Mark ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0342629663     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-4399(91)90038-W     Document Type: Article

References (45)

1. New antifungal agents
2. Azole antifungal agents: emphasis on new triazoles
3. Azole antifungals: old and new
4. Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH 39304
5. Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals
6. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis
7. Evaluation of Nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis
8. The development of strains of Candida albicans and Coccidioides immitis which are resistant to amphotericin B
9. Antifungal susceptibility tests
10. In vitro and in vivo evaluation of antifungal agents
11. In vitro susceptibility testing and measurement of levels of antifungal agents in body fluids
12. Laboratory tests with antifungal agents
13. Standardization of antifungal susceptibility testing
14. Progress in standardizing antifungal susceptibility tests
15. Antifungal susceptibility testing
16. Laboratory studies with antifungal agents: susceptibility tests and bioassays
17. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin
18. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods
19. Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size
20. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts
21. Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome
22. Collaborative investigation of variables in susceptibility testing of yeasts
23. Factors influencing the susceptibility of Candida albicans to the polyene antibiotics nystatin and amphotericin B
24. Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo
25. pH and other effects on the antifungal activity of cilofungin (LY121019)
26. Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media
27. Effect of buffers on testing of Candida species susceptibility to flucytosine
28. Turbidimetric studies of growth inhibition of yeast with three drugs: inquiry into inoculum-dependent susceptibility testing, times of onset of drug effect, and implications for current and newer methods
29. In vitro susceptibilities of yeast to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy
30. Multicenter evaluation of four methods of yeast inoculum preparation
31. Broth dilution testing of Candida albicans susceptibility to ketoconazole
32. Improved method for azole antifungal susceptibility testing
33. Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions
34. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model
35. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida ablicans
36. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum
37. Testing of organisms for susceptibility to triazoles: is it justified?
38. Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing
39. Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts
40. Development of in vitro susceptibility testing criteria and quality control parameters
41. Interpretive guidelines for antimicrobiol test results: what do they mean?